Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator

Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator

US Patent 9701639 · Granted Jul 11, 2017

Estimated economic value: $141,957,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Stable polymorph of R-MDMA HCl2025
N, n-dimethyltryptamine salts and crystalline salt forms2025
Modulators of alpha-1 antitrypsin2025
Crystalline forms of CFTR modulators2025
Pharmaceutical composition and administrations thereof2025
Pharmaceutical composition and administrations thereof2025
N—N-dimethyltryptamine (DMT) and DMT analog compositions, methods of making, and2024
Crystalline forms of 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-2024
Inhibitors of APOL1 and methods of using same2024
Synthesis of MDMA or its optically active (R)- or (S)-MDMA isomers2024
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane c2024
Modulators of alpha-1 antitrypsin2024